Serotonin solves decades-old mystery in Parkinson's disease

Jun 30, 2010
PET image of a healthy brain. Credit: Image courtesy of Marios Politis

Sudden, uncontrolled movements called dyskinesias—a common side effect of treatment for Parkinson’s disease— are a result of excess serotonin cells in transplanted tissue that trick the brain into releasing dopamine, suggests a new study of two Parkinson's disease patients that received fetal tissue transplants over a decade ago, researchers report in the June 30 issue of Science Translational Medicine.

The study sheds light on the long term consequences of brain tissue transplants and may help improve future trials that consist of transplanting cells from other sources, such as bioengineered cells or . Pioneering surgeries performed with aborted fetal tissue in the 1980’s in patients with Parkinson’s proved that the diseased brain could be repaired, at least in some cases. The treatment aimed to replace decayed cells in the brain’s of Parkinson’s patients. Some transplanted patients showed remarkable improvement but eventually the majority developed dyskinesias.

The controversy surrounding the transplantation of fetal into adults put an end to human trials in the United States in the late 1980’s when the U.S. government temporarily banned fetal tissue research, though research continued in other parts of the world. The U.S. ban was lifted in the early 1990’s, but the cause of dyskinesias in these patients remained a mystery, and no effective treatment has been found.

Now, Marios Politis and colleagues in the United Kingdom and Sweden have discovered that the is the culprit. Using imaging scans and radioactive tracers, the researchers were able to visualize the function of different chemicals in the two patient’s brains. Taking a closer look, they found that previously decayed dopamine neurons—a hallmark of Parkinson’s disease—were still restored and fully functional over a decade after transplantation. But Politis and colleagues also saw unexpectedly high amounts of serotonin neurons in the transplanted tissue.

The finding is puzzling because the usual dyskinesias in Parkinson’s are thought to be a result of dopamine action, not serotonin. The researchers discovered that the deceptive ability of serotonin neurons to switch to a different neurotransmitter—to adopt and pump out dopamine—causes the dyskinesias. Administering a drug to block this action almost immediately eliminated the dyskinesias in both patients. The authors also suggest that removing in any future cell-based therapies might prevent this crippling side effect. Recently, a new trial launched under the name TRANSEURO plans to use fetal cell therapy to treat , with the first surgeries planned in 2012.

Explore further: First vital step in fertilization between sperm and egg discovered

More information: "Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants," by M. Politis et al. Science Translational Medicine.

add to favorites email to friend print save as pdf

Related Stories

Replacing the cells lost in Parkinson disease

Dec 03, 2007

Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells. Replacing these cells is considered a promising therapeutic strategy. Although DA cell–replacement therapy by ...

What causes motor complications of Parkinson's treatment?

Jan 29, 2009

People with Parkinson's disease commonly suffer a slowing or freezing of movement caused by the death of neurons that make dopamine, a key chemical that allows brain cells to send and receive messages essential ...

Recommended for you

Gate for bacterial toxins found

9 hours ago

Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

starofbrain
not rated yet Jul 07, 2010
How can there be an excess of serotonin in Parkinson's? Serotonin is responsible for happiness (among other things) - and a deficiency of the neurotransmitter leads to depression, which is strongly connected to PD itself. In fact, many patients with Parkinson's - more than 50% - are also diagnosed with depression. Wouldn't it make sense if there was less - rather than an excess of - serotonin?
It would be great if you could clear this up for me. Thanks.

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Simplicity is key to co-operative robots

A way of making hundreds—or even thousands—of tiny robots cluster to carry out tasks without using any memory or processing power has been developed by engineers at the University of Sheffield, UK.

Progress in the fight against quantum dissipation

(Phys.org) —Scientists at Yale have confirmed a 50-year-old, previously untested theoretical prediction in physics and improved the energy storage time of a quantum switch by several orders of magnitude. ...